Optimi Health Corp (OPTH)

개요 뉴스 가격 이력 토론 예측 주식 분할

Relative Volume:

Optimi Health Corp Stock (OPTH) Company Profile

Optimi Health Corp

Healthcare (1052)

최신 SEC 제출 서류

OPTH's Discussions on Twitter

Compare OPTH vs TAK, TEVA, HLN, ZTS, UTHR

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
OPTH Optimi Health Corp	3.38	19.35M	257.00K	-3.07M	-1.40M	-0.9527
TAK Takeda Pharmaceutical Co Adr	19.67	62.84B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.50	48.40B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	10.13	44.55B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	79.38	32.80B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	533.12	22.87B	3.17B	1.29B	1.01B	27.09

Optimi Health Corp 주식(OPTH)의 최신 뉴스

Optimi Health Corp (OPTH) 재무 분석

Optimi Health Corp (OPTH)

Optimi Health Corp Stock (OPTH) Company Profile

Compare OPTH vs TAK, TEVA, HLN, ZTS, UTHR

Optimi Health Corp 주식(OPTH)의 최신 뉴스

Optimi Health to Present at the ThinkEquity Conference - GlobeNewswire Inc.

Optimi Health Corp. (OPTI.CN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Optimi Health releases 5 mg psilocybin batch for Canadian Phase 2 trial - mugglehead.com

Optimi Health Corp. Common Shares (NASDAQ: OPTH) Stock Price, News & Analysis - kalkine.com.au

Optimi Health Corp. Plans Health Canada-Authorized Phase 3 Trial of MDMA-Assisted Therapy for PTSD - Quiver Quantitative

Optimi Health Corp Share PriceOPTI, RNS News, Articles, Quotes, & Charts (CNSX:OPTI) - Proactive financial news

OPTI: Commercially supplying natural psychedelics, expanding globally as regulations advance - TradingView

Optimi Health at H.C. Wainwright conference: early lead in psychedelics - Investing.com

OPTI: Commercial psychedelic manufacturer expands globally as regulatory momentum accelerates - TradingView

Optimi Health Corp. (CN:OPTI) Advances as Psychedelic Medicine Pipeline and Clinical Expansion Improve Investor Sentiment - kalkine.ca

Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com Nigeria

Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com South Africa

OPTH Stock Price, Quote & News - Syfe

OPTH Looks 64.2% Overvalued on GF Value™ - GuruFocus

Optimi Health Launches Health Canada-Authorized Phase 2 Psilocybin Trial for Major Depressive Disorder - kalkine.ca

Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com Canada

Optimi Health To Initiate Phase 2 Psilocybin Trial For Major Depression - RTTNews

Optimi Health plans phase 2 psilocybin trial for depression - Investing.com

Optimi Health CorpTrial Initiation Planned For H1 2027, Dosing To Complete By End Of 2027 - TradingView

Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com India

Optimi Health Announces Health Canada-Authorized Phase 2 Trial of Natural Psilocybin for Major Depressive Disorder - Quiver Quantitative

A 200-person psilocybin depression trial is coming from Optimi Health (OPTH); here’s when and where - Stock Titan

Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder - Yahoo Finance

Optimi Health Stock Under Pressure: Can Psychedelic Growth Overcome Rising Execution and Funding Risks? - kalkine.ca

Optimi Health to Present at H.C. Wainwright Global Investment Conference - TipRanks

Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Investing News Network

Optimi Health Corp. to Present at H.C. Wainwright 28th Annual Global Investment Conference in September 2026 - kalkine.ca

Psychedelic-drug maker Optimi Health (OPTH) plans investor meetings in New York - Stock Titan

Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance

Optimi Health Stock Faces Renewed Pressure as Psychedelic-Sector Sentiment Weakens - kalkine.ca

Optimi Health (CN:OPTI) Drops 4.12% as Revenue Weakness, Funding Risk and Psychedelic-Sector Uncertainty Pressure Sentiment - kalkine.ca

Optimi Health Corp (CN: OPTI) Share Price, OPTI Stock News, OPTI Share Price & Updates - kalkine.ca

Optimi Health (OPTH) lines up discounted share funding with new $100M facility - Stock Titan

Optimi Health Corp. Common Shares (NASDAQ: OPTH) Stock Price, News & Analysis - kalkine.ca

Optimi Health Corp. SEC Filing (Aug 26, 2026) - Stock Titan

3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now - Yahoo! Finance Canada

3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now - Yahoo Finance

Optimi Health Establishes $100 Million Equity Facility as Psychedelic Commercialisation Advances - Yahoo Finance

Optimi Health (OPTH) Stock Chart and Price History 2026 - MarketBeat

Optimi Health Sets Up US$100 Million Equity Line for Psychedelic Drug Expansion - TipRanks

Optimi Health (OPTH) clears way for resale of shares over 3x its float - Stock Titan

Optimi Health (OPTH) secures US$100M equity line with convertible note sweeteners - Stock Titan

Optimi Health Corp. Establishes US$100 Million Discretionary Equity Line of Credit with Seven Knots - kalkine.ca

Optimi Health (OPTH) raises $20.7M, posts larger loss and builds cash buffer - Stock Titan

Optimi Health Corp. Announces Up to US$100 Million Equity Line of Credit with Seven Knots | OPTH Stock News - Quiver Quantitative

Optimi Health Establishes Discretionary Equity Facility - Yahoo Finance

Optimi Health Corp. Announces Up to US$100 Million Equity Line of Credit with Seven Knots - Quiver Quantitative

Optimi Health Establishes Discretionary Equity Facility - globenewswire.com

Norton Rose Fulbright advises Optimi Health on equity facility - Norton Rose Fulbright

Norton Rose Fulbright advises Optimi Health on equity facility - Norton Rose Fulbright

Optimi Health Corp (OPTH) 재무 분석

매출

순이익

현금흐름

주당 순 이익

OPTH과 유사한 종목